Advertisement

The Immunostimulatory, Anti-Inflammatory and Anti-Allergic Properties of Ascorbate

  • Ronald Anderson
Chapter
Part of the Advances in Nutritional Research book series (ASIB, volume 110)

Abstract

Assessment of the effects of single nutrient supplements given to normal or immunocompromised individuals and of single nutrient deficiency states on cellular and humoral immune functions is a field of considerable interest which has led to the development of the science of nutritional immunology. Of the vitamins investigated, ascorbate has received most attention. Interest in ascorbate as an immunostimulatory agent is due largely to the wide publicity given to the theories and claims of Linus Pauling. However, the role of ascorbate as a potentially important immunomodulator remains controversial. Many investigators have attempted to evaluate the vitamin in the therapy and prevention of various diseases such as the common cold and in individuals with different types of cancer. In most investigations no attempt was made to identify which components of the immune system were compromised in individuals with the various diseases studied or which cellular and humoral immune functions are altered during ingestion of large doses of vitamin C. Furthermore, many studies have been performed using dosages of ascorbate ranging from milligram amounts to 70 g daily or greater in the absence of adequate data relating to the in vivo for enhancement of specific immune functions.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anah, C.O., Jarike, L.N., and Baig, H.A., 1980, High dose ascorbic acid in Nigerian asthmatics, Trop. Geogr,. Med.32: 132Google Scholar
  2. Anderson, R., 1979, Effects of ascorbate on leucocytes, Part II,. Effects of ascorbic acid and calcium and sodium ascorbate on neutrophil phagocytosis and post-phagocytic metabolic activity, S. Afr. Med. J 56: 401.Google Scholar
  3. Anderson, R., 1981a, Ascorbate mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of the peroxidase/H202/halide systemin vitroandin vivo, Am. J. Clin. Nutr 34: 1906.Google Scholar
  4. Anderson, R., 1981b, Assessment of oral ascorbate in three children with chronic granulomatous disease and defective neutrophil motility over a 2-year period, Clin,. Exp. Immunol 43: 180Google Scholar
  5. Anderson, R., and Grabow, G., 1980, In vitro stimulation of neutrophil motility by metoprolol and sotalol related to inhibition of both H202 production and peroxidase mediated iodination of the cell and leukoattractant, Int. J. Immunopharmac 2: 321CrossRefGoogle Scholar
  6. Anderson, R., and Jones, P.T., 1982, Increased leukoattractant binding and reversible inhibition of neutrophil motility mediated by the peroxidase/H202/halide system: effects of ascorbate, cysteine, dithiothreitol, levamisole and thiamine, Clin. Exp. Immunol 47: 487Google Scholar
  7. Anderson, R., and Theron, A., 1979a, Effects of ascorbate on leucocytes, Part I. Effects of ascorbate on neutrophil motility and intracellular cyclic nucleotide levelsin vitro, S. Afr. Med. J.56: 394Google Scholar
  8. Anderson, R., and Theron, A., 1979b, Effects of ascorbate on leucocytes, Part III,. In vitro and in vivo stimulation of abnormal neutrophil motility by ascorbate, S. Afr. Med. J. 56: 429Google Scholar
  9. Anderson, R., and Van Rensburg, A.J., 1979, Thein vitroeffects of propranolol and atenolol on neutrophil motility and postphagocytic metabolic activity, Immunology 37: 15.Google Scholar
  10. Anderson, R., Hay, I., Van Wyk, H., Oosthuizen, R., and Theron, A., 1980a, The effects of ascorbate on cellular and humoral immunity in ten selected asthmatic children, S. Afr. Med. J 58: 974Google Scholar
  11. Anderson, R., Oosthuizen, R., Maritz, R., Theron, A., and Van Rensburg, A.J., 1980b, The effects of increasing weekly doses of ascorbate on certain cellular and humoral immune functions in volunteers, Am. J. Clin. Nutr 33: 71Google Scholar
  12. Atkinson, J.P., Kelly, J.P., Weiss, A., Wedner, H.J., and Parker, C.W., 1978, Enhanced intracellular cGMP concentrations and lectin-induced lymphocyte transformation, J. Immunol 121: 2282Google Scholar
  13. Becker, E.L., Showell, H.J., Henson, P.M., and Hus, L.S., 1974, The ability of chemotactic factors to induce lysozomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness, J. Immunol 112: 2047Google Scholar
  14. Becker, E.L., Sigman, M., Oliver, J.M., 1979, Superoxide production induced in rabbit leukocytes by synthetic chemotactic peptides and A23187., Am. J. Path 48: 288Google Scholar
  15. Bodaness, R.S., and Chan, P.G., 1979, Ascorbic acid as a scavenger of singlet oxygen., FEBS Lett.105: 195CrossRefGoogle Scholar
  16. Boxer, L.A., Watanabe, A.M., Rister, M., Besch, H.R., Allen, J., and Baehner, R.L., 1976, Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate, N. Engl. J. Med 295: 1041CrossRefGoogle Scholar
  17. Bradley, P., and Rothstein, G., 1981, Release of myeloperoxidase during inflammation., Clin. Res.29: 330A (abstract)Google Scholar
  18. Brink, C., Ridgway, P., and Douglas, J.S., 1978, Regulation of guinea-pig airwaysin vivoby endogenous prostaglandins,, Pol. J. Pharmacol. Pharm 30: 157Google Scholar
  19. Carp, H., and Janoff, A., 1980, Potential mediator of inflammation: Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha-l-proteinase inhibitorin vitro, J. Clin. Invest.66: 987CrossRefGoogle Scholar
  20. Chatterjee, I.B., Majumder, A.K., Nandi, B.K., and Subramanian, N., 1975, Synthesis and some major functions of vitamin C, Ann. N.Y. Acad. Sci 258: 24CrossRefGoogle Scholar
  21. Clark, R. A., and Klebanoff, S.J., 1979, Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system: an inflammatory control mechanism, J. Clin. Invest 64: 913CrossRefGoogle Scholar
  22. Coffey, R., Hadden, E.M., and Hadden, J.W., 1977, Evidence for cyclic GMP and calcium mediation of lymphocyte activation by mitogens, J. Immunol 119: 1387Google Scholar
  23. Dallegri, F., Lanzi, G., and Patrone, F., 1980, Effects of ascorbic acid on neutrophil locomotion., Int. Archs. Allergy Appl. Immun 61: 40CrossRefGoogle Scholar
  24. De Chatelet, L.R., Cooper, M.R., and McCall, C.E., 1972, Stimulation of the hexose monophosphate shunt in human neutrophils by ascorbic acid. Mechanisms of action, Antimicrob. Agents Chemother 1: 12CrossRefGoogle Scholar
  25. De Chatelet, L.R., McCall, C.E., Cooper, M.R., and Shirley, P.S., 1974, Ascorbate levels in phagocytic cells, Proc. Soc. Exp. Biol. Med 145: 1170CrossRefGoogle Scholar
  26. Ericsson, Y., and Lundbeck, H., 1955, Antimicrobial effect in vitro of the ascorbic acid oxidation,. II. Influence of various chemical and physical factors, Acta. Pathol. Microbiol. Scand 37: 507CrossRefGoogle Scholar
  27. Friedenberg, W.R., Marx, J.J., Hansen, R.L., and Haselby, R.C., 1979, Hyperimmunoglobulin E syndrome: Response to transfer factor and ascorbic acid therapy, Clin. Immunol. Immunopathol 12: 132CrossRefGoogle Scholar
  28. Gallin, J.I., Sandler, J.A., Clyman, R.I., Manganiello, V.C., and Vaughan, M., 1978, Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion, J. Immunol 120: 492Google Scholar
  29. Goetzl, E.J., 1980, Mediators of immediate hypersensitivity derived from arachidonic acid, N. Engl. J. Med 303: 822CrossRefGoogle Scholar
  30. Goetzl, E.J., Wasserman, S.I., Gigli, I., and Austen, K.F., 1974, Enhancement of random migration and chemotactic responses of human leukocytes by ascorbic acid., J. Clin. Invest 53813.Google Scholar
  31. Goetzl, E.J., Wasserman, S.I., Gigli, I., and Austen, K.F., 1974, Enhancement of random migration and chemotactic responses of human leukocytes by ascorbic acid., J. Clin. Invest 53: 813CrossRefGoogle Scholar
  32. Goldberg, N.D., and Haddox, M.K., 1977, Cyclic GMP metabolism in biological regulation., Ann. Rev. Biochem 46: 823CrossRefGoogle Scholar
  33. Greendyke, R.M., Brierty, R.E., and Swisher, S.N., 1964, In vitrostudies on erythrophayocytosis., II. Effects of incubating leokocytes with selected cell metabolites, J. Lab. Clin. Med 63: 1016Google Scholar
  34. Greenwald, R.A., and Moy, W.W., 1979, Inhibition of collagen gelation by action of the superoxide radical., Arthritis Rheum.22: 251CrossRefGoogle Scholar
  35. Greenwald, R.A., Moy, W.W., and Lazarus, D., 1977, Degradation of cartilage proteoglycans and collagen by superoxide radical., Arthritis Rheum.19: 799Google Scholar
  36. Halliwell, B., 1978, Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: The key role of superoxide dismutase, Cell Biol. Internat. Reports 2: 113CrossRefGoogle Scholar
  37. Harrison, J.E., and Schultz, J., 1976, Studies on the chlorinating activity of myeloperoxidase, J. Biol. Chem 251: 1371.Google Scholar
  38. Johnson, R.A., and Green, F.D., 1975, Chlorination with N-chloro amides., 1. Inter- and intra-molecular chlorination.J. Org. Chem 40: 2186.CrossRefGoogle Scholar
  39. Johnson, R.A., and Green, F.D., 1975, Chlorination with N-chloro amides., 1. Inter- and intra-molecular chlorination.J. Org. Chem 40: 2186.CrossRefGoogle Scholar
  40. Jori, G., Galiazzo, G., Marzotto, A., and Scoffone, E., 1968, Selective and reversible photo-oxidation of the methionyl residues in lysozyme, J. Biol. Chem 243: 4272Google Scholar
  41. Klebanoff, S.J., and Clark, R.A., 1978, The Neutrophil. Function and Clinical Disorders, p. 409 North-Holland Pub,. Co., Amsterdam.Google Scholar
  42. Kordansky, D.V., Rosenthal, R.R., and Norman, P.S., 1979, The effects of vitamin C on antigen-induced bronchospasm, J. Allergy Clin. Immunol 63: 61CrossRefGoogle Scholar
  43. Kreisman, H., Mitchell, C., and Bouhuys, A., 1977, Inhibition of histamine-induced airway constriction., Negative results with oxtriphyline and ascorbic acid, Lung 154: 223.CrossRefGoogle Scholar
  44. Levene, C.I., and Bates, C.J., 1976, The effect of hypoxia on collagen synthesis in cultured 3T6 fibroblasts and its relationship to the mode of action of ascorbate, Biochim. Biophys. Acta, 444: 446.CrossRefGoogle Scholar
  45. Loh, H.S., and Wilson, C.W.M., 1970, The origin of ascorbic acid stored in leucocytes, Br. J. Pharmacol. Chemother.40: 169Google Scholar
  46. Manku, M.S., Oka, M., and Horrobin, D.F., 1979, Differential formation of prostaglandins and related substances from arachidonic acid,. II. Effects of vitamin C, Prostaglandins Med.3: 129.CrossRefGoogle Scholar
  47. Manzella, J.P., and Roberts, N.J., 1979, Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid and hyperthermia., J. Immunol 123: 1940.Google Scholar
  48. Mathé, A.A., and Hedqvist, P., 1975, Effect of prostaglandins F2α, and E2 on airway conductance in healthy subjects and asthmatic patients, Am. Rev. Resp. Dis 111: 313.Google Scholar
  49. McCall, C.E., De Chatelet, L.R., Cooper, M.R., and Ashburn, P., 1971, The effects of ascorbic acid on bacteriocidal mechanisms of neutrophils, J. Infec. Dis 124: 194.CrossRefGoogle Scholar
  50. McCord, J.M., 1974, Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase, Science 185: 529CrossRefGoogle Scholar
  51. Miller, T.E., 1969, Killing and lysis of Gram-negative bacteria through the synergistic effect of hydrogen peroxide, ascorbic acid and lysozyme, J. Bact 98: 949.Google Scholar
  52. Munster, A.M., Loadholdt, C.B., Leary, A.G., and Barnes, M.A., 1977, The effect of antibiotics on cell-mediated immunity, Surgery, 81: 692.Google Scholar
  53. Ogilvy, C.S., Douglas, J.S., Tabatabai, M., and Du Bois, A. B., 1978, Ascorbic acid reverses bronchoconstriction caused by metacholine aerosol in man: Indomethacin prevents this reversal, Physiologist, 21: 86.Google Scholar
  54. Oliver, J.M., Spielberg, S.P., Pearson, C.B., and Schulman, J.D., 1978, Microtubule assembly and function in normal and glutathione synthetase deficient polymorphonuclear leukocytes, J. Immunol 120: 1181.Google Scholar
  55. Orehek, J., Douglas, J.S., Lewis, A.J., and Bouhuys, A., 1973, Prostaglandin regulation of airway smooth muscle tone., Nature New Biol.245: 84.CrossRefGoogle Scholar
  56. Orehek, J., Douglas, J.S., and Bouhuys, A., 1975, Contractile responses of the guinea-pig trachea in vitro: Modification by prostaglandin synthetase-inhibiting drugs, J. Pharmacol. Exp. Ther 194: 554.Google Scholar
  57. Orr, C.W.M., 1967, Studies on ascorbic acid. I. Factors influencing the ascorbate-mediated inhibition of catalase, Biochemistry, 6: 2995.CrossRefGoogle Scholar
  58. Panush, R.S., and Delafuente, J.C., 1979, Modulation of certain immunologic responses by vitamin C.,. Internat.J. Vit. Nutr. Res., Suppl 19: 179.Google Scholar
  59. Panush, R.S., Delafuente, J.C., Katz, P., and Johnson, J., 1981, Modulation of certain immunologic responses by vitamin C. III,. Potentiation ofin vitroandin vivolymphocyte responses., Int. J. Vit. Nutr. Res. Suppl 20: 35Google Scholar
  60. Pugh, D.M., Sharma, S.C., and Wilson, C.W.M., 1975, Inhibitory effect of L-ascorbic acid on the yield of prostaglandin F from the guinea-pig uterine homogenates., Br. J. Pharmacol 53: 469Google Scholar
  61. Rebora, A., Crovato, F., Dallegri, F., and Patrone, F., 1980, Repeated staphylococcal pyoderma in two siblings with defective neutrophil bacterial killin. g, Dermatologica 160: 106CrossRefGoogle Scholar
  62. Rebora, A., Dallegri, F., and Patrone, F., 1980, Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid, Brit. J. Dermatol 102: 49CrossRefGoogle Scholar
  63. Sacks, T., Moldow, C.F., Craddock, P.R., Bowers, T.K., and Jacob, H.S., 1978, Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. Anin vitromodel of immune vascular damage, J. Clin. Invest 61: 116Google Scholar
  64. Samuelsson, B., Hammarstrom, S., Murphy, R.C., and Borgeat, P., 1980, Leukotrienes and slow reacting substance of anaphylaxis, Allergy, 35: 375CrossRefGoogle Scholar
  65. Sandler, J.A., Gallin, J.I., and Vaughan, M., 1975, The effects of serotonin, carbamylcholine and ascorbic acid on leukocyte cyclic GMP and chemotaxis, J. Cell Biol 67: 480.CrossRefGoogle Scholar
  66. Schwartz, E.R., 1979, Vitamin C: Effect on arylsulfatase activities and sulfated proteoglycan metabolism in cultures derived from human articular cartilage, Int. J. Vit. Nutr. Res. Suppl 19: 113Google Scholar
  67. Schwartz, E.R, Ogle, R.C., and Thompson, R.C., 1974, Aryl sulfatase activities in normal and pathologic human articular cartilage., Arthritis Rheum.17: 455CrossRefGoogle Scholar
  68. Siegel, B.V., and Morton, J.I., 1977, Vitamin C and the immune response, Experientia 33: 393CrossRefGoogle Scholar
  69. Simon, L.S., and Mills, J.A., 1980, Non-steroidal anti-inflammatory drugs, N. Engl. J. Med 302: 1179CrossRefGoogle Scholar
  70. Skosey, J.L., and Chow, D.C., 1981, A mechanism for the therapeutic actions of gold salts and D-penicillamine in rheumatoid arthritis., Clin. Res.29: 559A (abstract)Google Scholar
  71. Smorgorzewska, E.M., Layward, L., and Soothill, J.F., 1981, T-lymphocyte mobility: defects and effects of ascorbic acid, histamine and complexed IgG, Clin. Exp. Immunol 43: 174.Google Scholar
  72. Subramanian, N., Nandi, B.K., Majumder, A.K., and Chatterjee, I.B., 1973, Role of L-ascorbic acid on detoxification of histamine., Biochem. Pharmacol 22: 1671.CrossRefGoogle Scholar
  73. Theron, A., Anderson, R., Grabow, G., and Meiring, J.L., 1981, In vitro and in vivo stimulation of neutrophil migration and lymphocyte transformation by thiamine related to inhibition of the peroxidase/H2,O2/halide system, Clin. Exp. Immunol 44: 295Google Scholar
  74. Thomas, E.L., and Aune, T.M., 1978a, Cofactor role of iodide in peroxidase antimicrobial action against, Escherichia coli Antimicro Agents Chemother,.13: 1000Google Scholar
  75. Thomas, E.L., and Aune, T.M., 1978b, Oxidation of Escherichia coli sulfhydryl components by the peroxidase-hydrogen peroxide-iodide antimicrobial system., Antimicrob. Agents Chemother, 13: 1006.CrossRefGoogle Scholar
  76. Weening, R.S., Schoorel, E.P., Roos, D., Van Schaik, M.L.J., Voetman, A.A., Bot, A.A.M., Batensburg-Plenter, A.M., Willems, C., Zeijlemaker, W.P., and Astaldi, A., 1981, Effect of ascorbate on abnormal neutrophil, platelet, and lymphocyte function in a patient with the Chediak-Higashi syndrome, Blood, 57: 85c.Google Scholar
  77. Wilkinson, P.C., 1976, Recognition and response in mononuclear and granular phagocytes., Clin. Exp. Immunol 25: 355Google Scholar
  78. Yamamoto, I., and Ohmori, H., 1981, Degradation of histamine in the presence of ascorbic acid and Cu2+ ion: Involvement of hydrogen peroxide, J. Pharm. Dyn 4: 15CrossRefGoogle Scholar
  79. Yonemoto, R.H., 1979, Vitamin C and the immune response in normal controls and cancer patients., Int. J. Vit. Nutr. Res. Suppl 19: 143Google Scholar
  80. Zurier, R.B., Weissmann, G.M., Hoffstein, S., Kammerman, S., and Tai, H.H., 1974, Mechanisms of lysozomal enzyme release from human leukocytes., II. Effects of CAMP and cGMP autonomic agonists and agents which affect microtubule function,, J. Clin. Invest 53: 297.CrossRefGoogle Scholar
  81. Zuskin, E., Lewis, A.J., and Bouhuys, A., 1973, Inhibition of histamine induced airway constriction by ascorbic acid, J. Allergy Clin. Immunol.51: 218CrossRefGoogle Scholar
  82. Zuskin, E., Valic, F., and Bouhuys, A., 1976, Byssinosis and airway responses due to exposure to textile dust, 1976, Lung, 154: 17CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Ronald Anderson
    • 1
  1. 1.The Immunology Section, Department of Medical Microbiology, Institute of PathologyUniversity of PretoriaRepublic of South Africa

Personalised recommendations